The risk of recurring breast cancer in patients is being assessed using AI in a trial in one of the world’s leading cancer centres.
At Gustave Roussey hospital in Paris, a non-intervention clinical trial is taking place using AI to digitise more than 1,500 tissue samples from women with breast cancer.
French and US tech company Owkin has partnered with the hospital to run the trial aiming to classify patients between having a high, intermediate or low risk of their disease returning within five years.
Patients are not told of the AI results to avoid the risk of life or death treatment decisions being based on them.
This film is from Click – the BBC’s weekly technology show.
Please subscribe HERE http://bit.ly/1rbfUog
#Click #BBCNews
MILANO (ITALPRESS) – All’Inter non riesce l’impresa, che l’avrebbe avvicinata agli ottavi di finale di Champions. A San Siro, nella…
COPENAGHEN (DANIMARCA) (ITALPRESS) – Un’occasione persa che rischia di costare caro. Il Napoli in emergenza non riesce a battere un…
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
Donald Trump has dismissed suggestions that his plan to take control of Greenland, in the face of opposition by his…
GUANGZHOU (CINA) (XINHUA/ITALPRESS) – Indossando un visore per la realtà virtuale, i visitatori possono viaggiare indietro nel tempo, nella Roma…
Today, the UK government has defended its decision to hand over the Chagos Islands after US President Donald Trump called…